HEADER TRANSFERASE 09-JAN-12 4AE6 TITLE STRUCTURE AND FUNCTION OF THE HUMAN SPERM-SPECIFIC ISOFORM OF TITLE 2 PROTEIN KINASE A (PKA) CATALYTIC SUBUNIT CALPHA 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PKA C-ALPHA, PKA C-ALPHA 2; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL: SPERMATOZOA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VARIANT: ROSETTA PLYSS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PET24 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.H.HERENG,P.H.BACKE,J.KAHMANN,C.SCHEICH,M.BJORAS,B.S.SKALHEGG, AUTHOR 2 K.R.ROSENDAL REVDAT 4 30-JAN-13 4AE6 1 JRNL MODRES REVDAT 3 06-JUN-12 4AE6 1 JRNL REVDAT 2 30-MAY-12 4AE6 1 JRNL REVDAT 1 18-APR-12 4AE6 0 JRNL AUTH T.H.HERENG,P.H.BACKE,J.KAHMANN,C.SCHEICH,M.BJORAS, JRNL AUTH 2 B.S.SKALHEGG,K.R.ROSENDAL JRNL TITL STRUCTURE AND FUNCTION OF THE HUMAN SPERM-SPECIFIC ISOFORM JRNL TITL 2 OF PROTEIN KINASE A (PKA) CATALYTIC SUBUNIT CALPHA2 JRNL REF J.STRUCT.BIOL. V. 178 300 2012 JRNL REFN ISSN 1047-8477 JRNL PMID 22504716 JRNL DOI 10.1016/J.JSB.2012.03.013 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 63.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 99.62 REMARK 3 NUMBER OF REFLECTIONS : 43775 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.21864 REMARK 3 R VALUE (WORKING SET) : 0.21517 REMARK 3 FREE R VALUE : 0.28328 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.1 REMARK 3 FREE R VALUE TEST SET COUNT : 2337 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.100 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.154 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3181 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.91 REMARK 3 BIN R VALUE (WORKING SET) : 0.240 REMARK 3 BIN FREE R VALUE SET COUNT : 171 REMARK 3 BIN FREE R VALUE : 0.310 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5384 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 255 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.558 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00 REMARK 3 B22 (A**2) : 0.00 REMARK 3 B33 (A**2) : 0.01 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.239 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.218 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.157 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.779 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.899 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5586 ; 0.022 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7558 ; 1.871 ; 1.955 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 668 ; 6.671 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 275 ;39.180 ;23.855 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1023 ;18.358 ;15.029 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;19.714 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 793 ; 0.131 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4229 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3256 ; 1.142 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5272 ; 1.990 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2330 ; 3.091 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2273 ; 4.801 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. U VALUES REFINED INDIVIDUALLY. REMARK 4 REMARK 4 4AE6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-JAN-12. REMARK 100 THE PDBE ID CODE IS EBI-50047. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97558 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46218 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.10 REMARK 200 RESOLUTION RANGE LOW (A) : 89.44 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NONE REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 5.83 REMARK 200 R MERGE (I) : 0.07 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.90 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 6.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.97 REMARK 200 R MERGE FOR SHELL (I) : 0.50 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.30 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1SMH REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 % PEG 3350, 0.2 M POTASSIUM REMARK 280 ACETATE, 5 % POLYPROPYLENE GLYCOL P400 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.88800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.40750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.74750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.40750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.88800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.74750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 8 REMARK 465 ALA A 9 REMARK 465 SER A 10 REMARK 465 ASN A 11 REMARK 465 LYS A 319 REMARK 465 GLY A 320 REMARK 465 PRO A 321 REMARK 465 GLY A 322 REMARK 465 ASP A 323 REMARK 465 THR A 324 REMARK 465 SER A 325 REMARK 465 ASN A 326 REMARK 465 PHE A 327 REMARK 465 ASP A 328 REMARK 465 ASP A 329 REMARK 465 TYR A 330 REMARK 465 GLU A 331 REMARK 465 GLU A 332 REMARK 465 GLU A 333 REMARK 465 GLU A 334 REMARK 465 ILE A 335 REMARK 465 ARG A 336 REMARK 465 MET B 8 REMARK 465 ALA B 9 REMARK 465 SER B 10 REMARK 465 ASN B 11 REMARK 465 SER B 12 REMARK 465 SER B 13 REMARK 465 ASP B 14 REMARK 465 VAL B 15 REMARK 465 LYS B 319 REMARK 465 GLY B 320 REMARK 465 PRO B 321 REMARK 465 GLY B 322 REMARK 465 ASP B 323 REMARK 465 THR B 324 REMARK 465 SER B 325 REMARK 465 ASN B 326 REMARK 465 PHE B 327 REMARK 465 ASP B 328 REMARK 465 ASP B 329 REMARK 465 TYR B 330 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLY A 253 O HOH A 2117 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2061 O HOH B 2112 3545 1.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 165 NE - CZ - NH1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG A 165 NE - CZ - NH2 ANGL. DEV. = -7.1 DEGREES REMARK 500 ASP A 184 CB - CG - OD1 ANGL. DEV. = 6.9 DEGREES REMARK 500 LYS A 217 CD - CE - NZ ANGL. DEV. = -15.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 46 -71.46 -102.00 REMARK 500 ASN A 99 119.40 -160.52 REMARK 500 ASP A 112 -158.10 -126.10 REMARK 500 ASP A 166 27.01 -143.47 REMARK 500 ASP B 112 -158.41 -130.61 REMARK 500 ASP B 166 24.66 -155.60 REMARK 500 LEU B 211 48.30 -92.38 REMARK 500 SER B 212 33.86 -2.99 REMARK 500 ASN B 216 -159.87 -127.65 REMARK 500 SER B 262 153.00 -44.18 REMARK 500 LEU B 273 32.80 -87.72 REMARK 500 LEU B 277 -53.06 -29.50 REMARK 500 ARG B 308 30.07 70.34 REMARK 500 VAL B 310 142.70 -39.60 REMARK 500 GLU B 334 160.37 -48.21 REMARK 500 CYS B 343 52.72 36.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 THR A 183 25.0 L L OUTSIDE RANGE REMARK 500 ARG B 165 24.0 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B1351 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4AE9 RELATED DB: PDB REMARK 900 STRUCTURE AND FUNCTION OF THE HUMAN SPERM-SPECIFIC ISOFORM REMARK 900 OF PROTEIN KINASE A (PKA) CATALYTIC SUBUNIT CALPHA 2 REMARK 999 REMARK 999 SEQUENCE REMARK 999 ISOFORM 2 DBREF 4AE6 A 8 350 UNP P17612 KAPCA_HUMAN 1 343 DBREF 4AE6 B 8 350 UNP P17612 KAPCA_HUMAN 1 343 SEQRES 1 A 343 MET ALA SER ASN SER SER ASP VAL LYS GLU PHE LEU ALA SEQRES 2 A 343 LYS ALA LYS GLU ASP PHE LEU LYS LYS TRP GLU SER PRO SEQRES 3 A 343 ALA GLN ASN THR ALA HIS LEU ASP GLN PHE GLU ARG ILE SEQRES 4 A 343 LYS THR LEU GLY THR GLY SER PHE GLY ARG VAL MET LEU SEQRES 5 A 343 VAL LYS HIS LYS GLU THR GLY ASN HIS TYR ALA MET LYS SEQRES 6 A 343 ILE LEU ASP LYS GLN LYS VAL VAL LYS LEU LYS GLN ILE SEQRES 7 A 343 GLU HIS THR LEU ASN GLU LYS ARG ILE LEU GLN ALA VAL SEQRES 8 A 343 ASN PHE PRO PHE LEU VAL LYS LEU GLU PHE SER PHE LYS SEQRES 9 A 343 ASP ASN SER ASN LEU TYR MET VAL MET GLU TYR VAL PRO SEQRES 10 A 343 GLY GLY GLU MET PHE SER HIS LEU ARG ARG ILE GLY ARG SEQRES 11 A 343 PHE SER GLU PRO HIS ALA ARG PHE TYR ALA ALA GLN ILE SEQRES 12 A 343 VAL LEU THR PHE GLU TYR LEU HIS SER LEU ASP LEU ILE SEQRES 13 A 343 TYR ARG ASP LEU LYS PRO GLU ASN LEU LEU ILE ASP GLN SEQRES 14 A 343 GLN GLY TYR ILE GLN VAL THR ASP PHE GLY PHE ALA LYS SEQRES 15 A 343 ARG VAL LYS GLY ARG THR TRP TPO LEU CYS GLY THR PRO SEQRES 16 A 343 GLU TYR LEU ALA PRO GLU ILE ILE LEU SER LYS GLY TYR SEQRES 17 A 343 ASN LYS ALA VAL ASP TRP TRP ALA LEU GLY VAL LEU ILE SEQRES 18 A 343 TYR GLU MET ALA ALA GLY TYR PRO PRO PHE PHE ALA ASP SEQRES 19 A 343 GLN PRO ILE GLN ILE TYR GLU LYS ILE VAL SER GLY LYS SEQRES 20 A 343 VAL ARG PHE PRO SER HIS PHE SER SER ASP LEU LYS ASP SEQRES 21 A 343 LEU LEU ARG ASN LEU LEU GLN VAL ASP LEU THR LYS ARG SEQRES 22 A 343 PHE GLY ASN LEU LYS ASN GLY VAL ASN ASP ILE LYS ASN SEQRES 23 A 343 HIS LYS TRP PHE ALA THR THR ASP TRP ILE ALA ILE TYR SEQRES 24 A 343 GLN ARG LYS VAL GLU ALA PRO PHE ILE PRO LYS PHE LYS SEQRES 25 A 343 GLY PRO GLY ASP THR SER ASN PHE ASP ASP TYR GLU GLU SEQRES 26 A 343 GLU GLU ILE ARG VAL SEP ILE ASN GLU LYS CYS GLY LYS SEQRES 27 A 343 GLU PHE SER GLU PHE SEQRES 1 B 343 MET ALA SER ASN SER SER ASP VAL LYS GLU PHE LEU ALA SEQRES 2 B 343 LYS ALA LYS GLU ASP PHE LEU LYS LYS TRP GLU SER PRO SEQRES 3 B 343 ALA GLN ASN THR ALA HIS LEU ASP GLN PHE GLU ARG ILE SEQRES 4 B 343 LYS THR LEU GLY THR GLY SER PHE GLY ARG VAL MET LEU SEQRES 5 B 343 VAL LYS HIS LYS GLU THR GLY ASN HIS TYR ALA MET LYS SEQRES 6 B 343 ILE LEU ASP LYS GLN LYS VAL VAL LYS LEU LYS GLN ILE SEQRES 7 B 343 GLU HIS THR LEU ASN GLU LYS ARG ILE LEU GLN ALA VAL SEQRES 8 B 343 ASN PHE PRO PHE LEU VAL LYS LEU GLU PHE SER PHE LYS SEQRES 9 B 343 ASP ASN SER ASN LEU TYR MET VAL MET GLU TYR VAL PRO SEQRES 10 B 343 GLY GLY GLU MET PHE SER HIS LEU ARG ARG ILE GLY ARG SEQRES 11 B 343 PHE SER GLU PRO HIS ALA ARG PHE TYR ALA ALA GLN ILE SEQRES 12 B 343 VAL LEU THR PHE GLU TYR LEU HIS SER LEU ASP LEU ILE SEQRES 13 B 343 TYR ARG ASP LEU LYS PRO GLU ASN LEU LEU ILE ASP GLN SEQRES 14 B 343 GLN GLY TYR ILE GLN VAL THR ASP PHE GLY PHE ALA LYS SEQRES 15 B 343 ARG VAL LYS GLY ARG THR TRP TPO LEU CYS GLY THR PRO SEQRES 16 B 343 GLU TYR LEU ALA PRO GLU ILE ILE LEU SER LYS GLY TYR SEQRES 17 B 343 ASN LYS ALA VAL ASP TRP TRP ALA LEU GLY VAL LEU ILE SEQRES 18 B 343 TYR GLU MET ALA ALA GLY TYR PRO PRO PHE PHE ALA ASP SEQRES 19 B 343 GLN PRO ILE GLN ILE TYR GLU LYS ILE VAL SER GLY LYS SEQRES 20 B 343 VAL ARG PHE PRO SER HIS PHE SER SER ASP LEU LYS ASP SEQRES 21 B 343 LEU LEU ARG ASN LEU LEU GLN VAL ASP LEU THR LYS ARG SEQRES 22 B 343 PHE GLY ASN LEU LYS ASN GLY VAL ASN ASP ILE LYS ASN SEQRES 23 B 343 HIS LYS TRP PHE ALA THR THR ASP TRP ILE ALA ILE TYR SEQRES 24 B 343 GLN ARG LYS VAL GLU ALA PRO PHE ILE PRO LYS PHE LYS SEQRES 25 B 343 GLY PRO GLY ASP THR SER ASN PHE ASP ASP TYR GLU GLU SEQRES 26 B 343 GLU GLU ILE ARG VAL SEP ILE ASN GLU LYS CYS GLY LYS SEQRES 27 B 343 GLU PHE SER GLU PHE MODRES 4AE6 TPO A 197 THR PHOSPHOTHREONINE MODRES 4AE6 SEP A 338 SER PHOSPHOSERINE MODRES 4AE6 TPO B 197 THR PHOSPHOTHREONINE MODRES 4AE6 SEP B 338 SER PHOSPHOSERINE HET TPO A 197 11 HET SEP A 338 10 HET TPO B 197 11 HET SEP B 338 10 HET ACT B1351 4 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM ACT ACETATE ION HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 3 TPO 2(C4 H10 N O6 P) FORMUL 4 SEP 2(C3 H8 N O6 P) FORMUL 5 ACT C2 H3 O2 1- FORMUL 6 HOH *255(H2 O) HELIX 1 1 SER A 12 SER A 32 1 21 HELIX 2 2 HIS A 39 ASP A 41 5 3 HELIX 3 3 LYS A 76 LEU A 82 1 7 HELIX 4 4 GLN A 84 GLN A 96 1 13 HELIX 5 5 GLU A 127 GLY A 136 1 10 HELIX 6 6 SER A 139 LEU A 160 1 22 HELIX 7 7 LYS A 168 GLU A 170 5 3 HELIX 8 8 THR A 201 LEU A 205 5 5 HELIX 9 9 ALA A 206 LEU A 211 1 6 HELIX 10 10 LYS A 217 GLY A 234 1 18 HELIX 11 11 GLN A 242 GLY A 253 1 12 HELIX 12 12 SER A 262 LEU A 273 1 12 HELIX 13 13 VAL A 288 ASN A 293 1 6 HELIX 14 14 HIS A 294 ALA A 298 5 5 HELIX 15 15 ASP A 301 GLN A 307 1 7 HELIX 16 16 GLU B 17 SER B 32 1 16 HELIX 17 17 HIS B 39 ASP B 41 5 3 HELIX 18 18 LYS B 76 LEU B 82 1 7 HELIX 19 19 GLN B 84 VAL B 98 1 15 HELIX 20 20 MET B 128 GLY B 136 1 9 HELIX 21 21 SER B 139 LEU B 160 1 22 HELIX 22 22 LYS B 168 GLU B 170 5 3 HELIX 23 23 THR B 201 LEU B 205 5 5 HELIX 24 24 ALA B 206 LEU B 211 1 6 HELIX 25 25 ALA B 218 GLY B 234 1 17 HELIX 26 26 GLN B 242 SER B 252 1 11 HELIX 27 27 SER B 262 LEU B 273 1 12 HELIX 28 28 VAL B 288 ASN B 293 1 6 HELIX 29 29 ASP B 301 GLN B 307 1 7 SHEET 1 AA 5 PHE A 43 THR A 51 0 SHEET 2 AA 5 ARG A 56 HIS A 62 -1 O VAL A 57 N LEU A 49 SHEET 3 AA 5 HIS A 68 ASP A 75 -1 O TYR A 69 N VAL A 60 SHEET 4 AA 5 ASN A 115 GLU A 121 -1 O LEU A 116 N LEU A 74 SHEET 5 AA 5 LEU A 106 LYS A 111 -1 N GLU A 107 O VAL A 119 SHEET 1 AB 2 LEU A 162 ILE A 163 0 SHEET 2 AB 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 AC 2 LEU A 172 ILE A 174 0 SHEET 2 AC 2 ILE A 180 VAL A 182 -1 O GLN A 181 N LEU A 173 SHEET 1 BA 5 PHE B 43 THR B 51 0 SHEET 2 BA 5 ARG B 56 HIS B 62 -1 O VAL B 57 N LEU B 49 SHEET 3 BA 5 HIS B 68 ASP B 75 -1 O TYR B 69 N VAL B 60 SHEET 4 BA 5 ASN B 115 GLU B 121 -1 O LEU B 116 N LEU B 74 SHEET 5 BA 5 LEU B 106 LYS B 111 -1 N GLU B 107 O VAL B 119 SHEET 1 BB 3 GLY B 125 GLU B 127 0 SHEET 2 BB 3 LEU B 172 ASP B 175 -1 O ILE B 174 N GLY B 126 SHEET 3 BB 3 ILE B 180 VAL B 182 -1 O GLN B 181 N LEU B 173 SHEET 1 BC 2 LEU B 162 ILE B 163 0 SHEET 2 BC 2 LYS B 189 ARG B 190 -1 O LYS B 189 N ILE B 163 LINK N TPO A 197 C TRP A 196 1555 1555 1.33 LINK C TPO A 197 N LEU A 198 1555 1555 1.34 LINK N SEP A 338 C VAL A 337 1555 1555 1.32 LINK C SEP A 338 N ILE A 339 1555 1555 1.33 LINK N TPO B 197 C TRP B 196 1555 1555 1.34 LINK C TPO B 197 N LEU B 198 1555 1555 1.33 LINK C SEP B 338 N ILE B 339 1555 1555 1.33 LINK N SEP B 338 C VAL B 337 1555 1555 1.34 SITE 1 AC1 3 GLY B 55 ARG B 56 ILE B 73 CRYST1 75.776 89.495 114.815 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013197 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011174 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008710 0.00000 MASTER 404 0 5 29 19 0 1 6 0 0 0 54 END